Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
[The biological role of sulfatides].
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Astrocytes in multiple sclerosis.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Pages